Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm
Ming-Yow Hung1, Kuang-Hung Hsu, Ming-Jui Hung
1Graduate Institute of Clinical Medical Sciences, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Insights
High-sensitivity C-reactive protein (hs-CRP) levels and their association with coronary vasospasm (CVsp) differ significantly between men and women. Hypertension appears to mitigate CVsp risk, suggesting distinct disease pathways.
Area of Science:
- Cardiology
- Inflammation Research
- Vascular Biology
Background:
- Coronary vasospasm (CVsp) is increasingly recognized as an inflammatory condition.
- Elevated high-sensitivity C-reactive protein (hs-CRP) levels are a marker of inflammation and have been linked to CVsp.
- Understanding the interplay of demographic and clinical factors with hs-CRP in CVsp is crucial for risk stratification.
Purpose of the Study:
- To investigate the differential associations of hs-CRP with CVsp in relation to gender, age, and hypertension.
- To explore the potential threshold and non-threshold models of hs-CRP in CVsp development.
- To elucidate the unique pathogenetic mechanisms of CVsp compared to coronary atherosclerosis.
Main Methods:
- Retrospective analysis of 722 Taiwanese patients with or without CVsp over 8 years.
- Exclusion of patients with obstructive coronary artery disease.
- hs-CRP levels analyzed in 375 patients to assess interactions with gender, age, smoking, and hypertension.
Main Results:
- In women, only the highest hs-CRP tertile (>3 mg/L) was independently associated with CVsp.
- In men, age >58 years and the highest hs-CRP tertile were independently associated with CVsp.
- Hypertension reduced the odds of CVsp in both genders, particularly in those with the highest hs-CRP levels.
Conclusions:
- The relationship between hs-CRP and CVsp is gender-dependent, with distinct threshold (women) and non-threshold (men) models observed.
- Age and lifestyle factors like smoking contribute to CVsp development in men.
- The mitigating effect of hypertension suggests CVsp pathogenesis differs from coronary atherosclerosis.
Background:
Coronary vasospasm (CVsp) has been reported to be an inflammatory disease, reflected by elevated high-sensitivity C-reactive protein (hs-CRP). We investigated the interactions among gender, age, hypertension and hs-CRP in patients with CVsp.
Materials And Methods:
We retrospectively examined 722 Taiwanese patients with or without CVsp during an 8-year period. None of the patients had obstructive coronary artery disease. Serum hs-CRP levels were examined in a subset of 375 patients to evaluate the interactions of hs-CRP with gender, age, smoking and hypertension in the development of CVsp.
Results:
In women, only the highest hs-CRP tertile (> 3 mg L⁻¹) was independently associated with CVsp. In men, age > 58 years and the highest hs-CRP tertile were independently associated with CVsp. In women, elevated risk was only demonstrated in patients ≤ 58 years of age with hs-CRP levels in the highest tertile. In men, a positively monotonic trend was demonstrated between hs-CRP levels and CVsp in those > 58 years of age. The odds ratios of CVsp in both women and men with hs-CRP in the highest tertile reduced from 6·01 to 1·48 and 6·35-2·69 respectively, if they had hypertension.
Conclusion:
The relationship between hs-CRP and CVsp differed between men and women. Our findings that there is a non-threshold model in men and a threshold model in women provide evidence that more smokers in men (life-style) and age (induction time) contribute to the natural history of CVsp development. The negative effect of hypertension on CVsp suggests that the pathogenesis of CVsp differs from that of coronary atherosclerosis.
Related Concept Videos
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

